Skip to main content
Frontiers in Public Health logoLink to Frontiers in Public Health
. 2024 Sep 18;12:1341378. doi: 10.3389/fpubh.2024.1341378

Prevalence, characteristics and risk factors of birth defects in central China livebirths, 2015–2022

Ping Luo 1,, Qian Li 1, Bin Yan 1, Yusha Xiong 2,, Ting Li 1, Xiao Ding 1, Bing Mei 1,*,
PMCID: PMC11445127  PMID: 39360259

Abstract

Objective

This study analyzed the prevalence, epidemiological characteristics and risk factors of birth defects among livebirths in central China, aiming to provide evidences for the prevention of birth defects and government Decision-makings.

Methods

Birth data from China’s Hubei Province between 2015 and 2022 were collected, including basic information of the livebirths, the mothers and the fathers, as well as information about delivery and each prenatal examination. The livebirths prevalence of birth defects was calculated and the trends were mapped. The basic characteristics of birth defects were evaluated by the difference analysis between case and health groups. Univariate and multivariate Poisson regression was performed to examine the independent risk factors for birth defects.

Results

Among 43,568 livebirths, 166 livebirths were born with birth defects, resulted in a total prevalence rate of 3.81 per 1,000 livebirths, showing a remarkable uptrend from 0.41per 1,000 livebirths in 2015 to 9.23 per 1,000 livebirths in 2022. The peak of the prevalence was in January and February. Congenital malformation of the musculoskeletal system was the main type of birth defect in central China livebirths, followed by cleft lip and cleft palate. Overall, newborns with birth defect had significantly earlier delivery gestational age, poorer health and higher proportion of infants with low birth weight than healthy births. The gender of livebirths, excess weight at delivery (≥80 kg) of mothers, more than 2 times of gravidity or parity of mothers, and advanced paternal age (≥40 years) were independent risk factors for birth defects (or specific birth defects).

Conclusion

The livebirths prevalence of birth defects shows increasing trend in central China, which deserves the attention of the government and would-be parents. Elevated paternal age, excess maternal weight, gravidity and parity should be considered when planning their families.

Keywords: birth defects, prevalence, risk factors, characteristics, epidemiology, congenital malformations, weight, age

1. Introduction

Birth defect is a worldwide public health problem, which brings misery to children and families and increases financial burden to the country and society (1, 2). Researchers and clinicians worldwide are trying their best to find risk factors for birth defects and are constantly improving prenatal screening and diagnostic techniques to minimize the prevalence. However, the prevalence of birth defect in China remains stubbornly high (3, 4), despite the efforts of the government, such as free premarital medical examination, free distribution of folic acid before and during pregnancy, free prenatal testing for chromosomal abnormalities and infectious diseases transmitted vertically from mother to child, continuous improvement of perinatal education and antenatal care services.

Although there have been a large number of epidemiological studies on birth defects, results regarding the prevalence and risk factors were inconsistent in different countries, even in different regions of the same country, due to differences in race, culture, living environment and government policies (3–6). The prevalence and types of birth defects have changed over time, too (4, 6). At present, investigations of birth defects in China have mainly focused on the provinces of Guangxi (7), Hunan (4, 8), Zhejiang (9) and Jiangsu (3), while fewer data in central China have been reported, especially in recent years. In this study, we analyzed the trends of prevalence and main types of birth defects among livebirths from 2015 to 2022 in central China, and further explored the risk factors, aiming to provide evidences for the prevention of birth defects and government Decision-making.

2. Methods

2.1. Data collection

The data used for analysis in this study was from the database of “HuBei Province Maternal and Children’s Health Services Information Management System” which recorded sociodemographic data of the fathers and mothers, information on each prenatal examination, and birth information of newborns born in Hubei Province. All hospitals in Hubei Province that offered service of prenatal examination and delivery care were required by policy to register and upload the above information into the system.

Every pregnant woman was provided Maternal and Child Health Handbook at the first prenatal examination, which was issued by the National Health Commission of China, used countrywide and integrated pregnancy health care, hospital delivery, child health care, child vaccination and family planning services. The handbook detailed the precautions during pregnancy, items and gestational weeks for prenatal examinations, which was personalized in different provinces according to local prevalence and economic conditions. For prenatal screening in Hubei Province, in addition to routine examinations and nutritional guidance for each prenatal examination, it was a routine screening for infectious diseases, thalassemia, fasting blood glucose and nuchal translucency (NT, a technique for detecting fetal chromosomal abnormalities by ultrasound) before 13 weeks of gestation, Down’s screening or Non-invasive Prenatal Testing (NIPT) at 14–20 gestational weeks, four-dimensional color Doppler ultrasound at 20–24 gestational weeks screening for congenital heart disease and other fetal malformations, and 75 g oral glucose tolerance test (OGTT) at 24–28 gestational weeks.

Birth defects were diagnosed by physical examination, ultrasonography, X-ray examination, and/or genetic diagnostic methods, based on the Chinese National Criteria of Birth Defects and Tiny Deformities and the clinical modification codes as congenital malformations, deformations, and chromosomal abnormalities (codes Q00–Q99) of the International Classification of Diseases, 10th Revision (ICD-10) (7). Trained clinicians from each registered hospital were responsible for the diagnostic confirmation and uploading it into the system.

Data of newborns who born in Hubei Province but did prenatal examinations outside Hubei Province, were not included in this study because these data were not uploaded to the database. This study only analyzed birth defects diagnosed in perinatal period. Fetuses aborted, induced and stillborn due to birth defects were excluded from our study.

Due to the heavy workload of data collation, verification and analysis, we downloaded all birth data of livebirths born in Gongan County, Jingzhou City, Hubei Province between January 2015 and May 2022 from the above system for analysis, given that the corresponding uploaded data in this area was relatively complete.

2.2. Categories of birth defect diagnoses in newborns

According to the 10th Revision of International Classification of Diseases, the specific codes for congenital malformations, deformations, and chromosomal abnormalities were Q00–Q99, which were further subdivided into Q00–Q07 (congenital malformations of the nervous system), Q10–Q18 (congenital malformations of eye, ear, face and neck), Q20–Q28 (congenital malformations of the circulatory system), Q30–Q34 (congenital malformations of the respiratory system), Q35–Q37 (cleft lip and cleft palate), Q38–Q45 (other congenital malformations of the digestive system), Q50–Q56 (congenital malformations of genital organs), Q60–Q64 (congenital malformations of the urinary system), Q65–Q79 (congenital malformations and deformations of the musculoskeletal system), Q80–Q89 (other congenital malformations), Q90–Q99 (chromosomal abnormalities). Infants with more than one defect category were included in each applicable major defect category.

2.3. Definition

Low birth weight infant: newborns with a birth weight of less than 2,500 g (10). Premature infant: infants up to 28 weeks gestation age but less than 37 weeks (10). Health status of newborns: infants with no complications at birth are assessed as good; infants with non-life-threatening complications are assessed as average; and infants with life-threatening complications are assessed as poor (11). Weight gained: the amount of weight a pregnant woman gains from the beginning of pregnancy to the moment of delivery (12). Abnormal pregnancy-labor history: history of miscarriage, induction, premature delivery, dystocia, stillbirth, birth defects, neonatal death, hydatidiform mole and ectopic pregnancy. High-risk pregnancy: pregnancy with risk factors as follows: (1) special basic condition of the mother (age < 18 years or age ≥ 35 years, weight ≤ 40 kg or weight > 80 kg, height ≤ 1.45 m, thoracic deformity, birth canal deformity and narrow pelvis); (2) history of abnormal pregnancy and childbirth (abortion ≥2 times, spontaneous abortion ≥3 times, preterm birth ≥2 times, years of infertility, history of stillbirth or neonatal death, history of vaginal dystocia, history of postpartum hemorrhage, history of oaf, history of neonatal hemolysis, pregnancy after fallopian tube anastomosis); (3) virus infection, occupational toxicant exposure, smoking or taking contraindicated drugs for pregnant women, and exposure to radioactivity; (4) pregnancy coexisted diseases (pregnancy complicated with heart disease, diabetes, hypertension, kidney disease, liver disease, tuberculosis, hyperthyroidism or hypothyroidism, hematologic disease, anemia, tumor, etc.); (5) pregnancy complication (gestational hypertension, prenatal hemorrhage, fetal malposition, threatened preterm birth, overdue pregnancy, abnormal amniotic fluid volume, twin or macrosomia, fetal intrauterine growth retardation, mother–child blood incompatibility, premature rupture of membranes, etc.); (6) factors of social environment and psychology (financial difficulties, poor transportation, alcoholism, anxiety, fear, mental disorders, depression, etc.). Exposure to suspected teratogens in the first trimester of pregnancy: virus infection, occupational toxicant exposure, smoking or taking contraindicated drugs for pregnant women, and exposure to radioactivity. The above three definitions (abnormal pregnancy-labor history, high-risk pregnancy, exposure to suspected teratogens in the first trimester of pregnancy) were from the China’s Guideline of preconception and prenatal care (2018) (13).

2.4. Ethical approval

Ethics approvals were obtained by the ethics committees of Jingzhou Hospital Affiliated to Yangtze University (number: 2022–049-01) and Gongan County Maternal and Child Health Care Hospital (number: 2022-02-01). This study followed the principles of the Declaration of Helsinki. Informed consent was waived by the committees.

2.5. Statistical analysis

The prevalence of birth defects was calculated using the method recommended by the European Surveillance of Congenital Anomalies (EUROCAT), which was calculated as the total number of livebirths with birth defects divided by the total number of livebirths (7, 14). Normality of distribution for continuous variables was tested by the Kolmogorov–Smirnov test. The basic characteristics of birth defects were evaluated by the difference analysis between case and control groups. Two-sample t test for continuous variables, and Chi-square test, Fisher’s exact test or Mann–Whitney U test for categorical variables were used to evaluate the difference in means and proportions between case and health groups. The Contingency coefficient C was calculated to evaluate the correlation and closeness degree when the difference in constituent ratio between the two groups was statistically significant. Univariate and multivariate Poisson regression was performed to examine the independent risk factors for birth defects. For this study, p < 0.05 was accepted as statistically significant. Analyses were performed with SPSS 25.0 software.

3. Results

3.1. Prevalence and trends of birth defects

A total of 43,568 livebirths were included in this study. Among them, 166 newborns were born with birth defects, giving a total prevalence rate of 3.81 per 1,000 livebirths. As shown in Figure 1, the livebirths prevalence of birth defects increased steadily every year, and the difference of prevalence was statistically significant (p < 0.001, not shown). Moreover, the peak of the prevalence was in January and February, meaning that newborns born in January and February have a higher prevalence of birth defects (Figure 2).

Figure 1.

Figure 1

Prevalence and trend of birth defects.

Figure 2.

Figure 2

Monthly trend of birth defects.

In this study, among the 166 livebirths with birth defects, 163 newborns were single-system birth defects (98.19%), and only 3 newborns were combined with multi-system birth defects (1.81%). A total of eight types of birth defects were observed in our study population, including congenital malformations of the nervous system (Q00–Q07), congenital malformations of eye, ear, face and neck (Q10–Q18), congenital malformations of the circulatory system (Q20–Q28), cleft lip and cleft palate (Q35–Q37), other congenital malformations of the digestive system (Q38–Q45), congenital malformations of genital organs (Q50–Q56), congenital malformations of the urinary system (Q60–Q64), congenital malformations and deformations of the musculoskeletal system (Q65–Q79). As shown in Figure 3, congenital malformations and deformations of the musculoskeletal system (Q65–Q79) was the main type of the birth defects in central China livebirths, followed by cleft lip and cleft palate (Q35–Q37) and congenital malformations of eye, ear, face and neck (Q10–Q18). The types of congenital malformations of the respiratory system (Q30–Q34), other congenital malformations (Q80–Q89) and chromosomal abnormalities (Q90–Q99) were not observed. More detailed classification on birth defects was shown in Table 1. As shown in Table 1, the top 3 types of birth defects were polydactyly (Q69), congenital malformation of the foot (Q66) and syndactyly (Q70).

Figure 3.

Figure 3

Subtypes and percentages of birth defects Q00–Q07: congenital malformations of the nervous system, Q10–Q18: congenital malformations of eye, ear, face and neck, Q20–Q28: congenital malformations of the circulatory system, Q35–Q37: cleft lip and cleft palate, Q38–Q45: other congenital malformations of the digestive system, Q50–Q56: congenital malformations of genital organs, Q60–Q64: congenital malformations of the urinary system, Q65–Q79: congenital malformations and deformations of the musculoskeletal system.

Table 1.

The birth defects classified by ICD-10.

Code Types of birth defects Percentage Rank
Congenital malformations of eye, ear, face and neck (Q10–Q18)
Q16 Congenital malformation of the ear causing hearing impairment 5.00% 4
Q17 Other congenital malformations of the ear 4.44% 5
Q18 Other congenital malformations of the face and neck 0.56% 12
Cleft lip and cleft palate (Q35–Q37)
Q35 Cleft palate 3.89% 6
Q36 Cleft lip 5.00% 4
Q37 Cleft lip and palate 2.22% 9
Congenital malformations and deformations of the musculoskeletal system (Q65–Q79)
Q65 Congenital malformations of the hip 1.11% 11
Q66 Congenital malformation of the foot 11.11% 2
Q67 Congenital musculoskeletal malformations of the head, face, spine, and thorax 0.56% 12
Q68 Other congenital musculoskeletal malformations 2.22% 9
Q69 Polydactyly 41.11% 1
Q70 Syndactyly 9.44% 3
Q71 Congenital malformation of short upper limb 1.67% 10
Q72 Congenital malformation of short lower limb 0.56% 12
Q74 Other congenital malformations of limbs 0.56% 12
Q75 Other congenital malformations of skull and facial bones 0.56% 12
Other birth defects
Q02 Microcephalus 0.56% 12
Q21 Congenital malformation of the cardiac septum 1.67% 10
Q39 Congenital malformation of the esophagus 0.56% 12
Q42 Congenital absence, atresia, and stenosis of large intestine 2.78% 8
Q54 Hypospadias 3.33% 7
Q55 Other congenital malformations of male reproductive organs 0.56% 12
Q61 Congenital renal cystic disease 0.56% 12

Infants with more than one defect category were included in each applicable major defect category.

3.2. Characteristics of birth defect

3.2.1. Characteristics of livebirths with birth defects

As shown in Table 2, livebirths in the overall birth defect group and Q65–Q79 subgroup had significantly shorter body length than those in the healthy group. However, these subtle differences (0.3 and 0.4 cm, respectively) showed no practical clinical significance, because a difference of 0.3 cm/0.4 cm May not have much effect on the future heights of livebirths. Second, livebirths in the overall birth defect group and the three subgroups all had poorer health than those in the healthy group. Although there is an association between birth defects and health status, the closeness degree is not very strong. The Contingency coefficients were 0.038, 0.018, 0.013, and 0.015, respectively. Third, although livebirths with birth defects had an earlier delivery gestational age, birth defects did not lead to a higher percentage of preterm births (more than 28 weeks gestation age but less than 37 weeks). However, it is worth noting that the gestational age at delivery were 37.76 ± 1.6 week in the Q10–Q18 subgroup and 38.68 ± 1.412 week in the healthy group, and the difference was statistically significant. The 95% confidence interval (CI) for gestational age at delivery in the Q10–Q18 subgroup ranged from 36.16 to 39.36 week, implying that some livebirths in the Q10–Q18 subgroup were premature babies (<37 gestational weeks). The relationship between Q10–Q18 subgroup and gestational age at delivery May have clinical significance, which needs to be verified by studies with a larger sample size. Fourth, the birth defect group had a similar birth weight to the health group, but the birth defect groups had a higher proportion of babies with low birth weight (<2,500 g) (the Q10–Q18 subgroup was an exception), although the correlation degrees were not strong. Fifth, livebirths with birth defects were mainly male (63.9% vs. 36.1% in overall group and 62.9% vs. 37.1% in Q65–Q79 subgroup, p = 0.001 and 0.013). The association degrees between gender and overall birth defects and Q65–Q79 subgroup were 1.5 and 1.2%, respectively. Differences in constituent ratio of gender between Q35–Q37 and Q10–Q18 subgroups and healthy group were not observed. Sixth, compared with healthy newborns, birth defects did not result in significant differences in placenta position, malpresentation and mode of delivery. There was no increase in the prevalence of birth defects due to multiple births and test-tube baby.

Table 2.

Characteristics of newborns with birth defects.

Variables Health group
(n = 43,402)
Birth defect group p/C*
Overall (n = 166) Q65–Q79
(n = 116)
Q35–Q37
(n = 20)
Q10–Q18
(n = 17)
Overall Q65–Q79 Q35–Q37 Q10–Q18
Length of the baby (cm) 49.91 ± 1.50 49.61 ± 1.63 49.51 ± 1.83 49.75 ± 1.07 19.53 ± 1.07 0.020 0.022 0.642 0.301
Birth weight of the newborns (g) 3,246 ± 437 3,187 ± 488 3,177 ± 513 3,164 ± 509 3,064 ± 497 0.081 0.089 0.398 0.086
Gestational age at delivery (week) 38.68 ± 1.412 38.46 ± 1.43 38.47 ± 1.45 38.45 ± 1.46 37.76 ± 1.6 0.046 0.122 0.472 0.008
Premature infant 0.826 0.667 1.000 0.078
No 41,146(94.8%) 158(95.2%) 111(95.7%) 19(95%) 14(82.4%)
Yes 2,256(5.2%) 8(4.8%) 5(4.3%) 1(5%) 3(17.6%)
Low birth weight infant 0.014/0.012 0.036/0.011 0.035/0.013 0.256
No 41,816(96.3%) 154(92.8%) 107(92.2%) 17(85%) 15(88.2%)
Yes 1,586(3.7%) 12(7.2%) 9(7.8%) 3(15%) 2(11.8%)
Placenta previa 0.543 0.371 1.000 1.000
No 43,346(99.9%) 165(99.4%) 115(99.1%) 20(100%) 17(100%)
Yes 56(0.1%) 1(0.6%) 1(0.9%) 0(0%) 0(0%)
Breech or transverse position 0.787 0.479 0.633 0.479
No 42,913(98.9%) 165(99.4%) 116(100%) 20(100%) 17(100%)
Yes 489(1.1%) 1(0.6%) 0(0%) 0(0%) 0(0%)
Delivery mode 0.117 0.188 0.237 0.224
Vaginal delivery 16,421(37.8%) 53(31.9%) 79(68.1%) 15(75%) 13(76.5%)
Cesarean section 26,981(62.2%) 113(68.1%) 37(31.9%) 5(25%) 4(23.5%)
Gender 0.001/0.015 0.013/0.012 0.745 0.539
Male 22,296(51.4%) 106(63.9%) 73(62.9%) 11(55%) 10(58.8%)
Female 21,106(48.6%) 60(36.1%) 43(37.1%) 9(45%) 7(41.2%)
Health status of newborns <0.001/0.038 <0.001/0.018 0.024//0.013 0.012/0.015
Good 39,693(91.5%) 123(74.1%) 95(81.9%) 15(75%) 12(70.6%)
Average or poor 3,709(8.5%) 43(25.9%) 21(18.1%) 5(25%) 5(29.4%)
Test-tube baby 0.796 0.990 0.628 1.000
No 42,847(98.7%) 163(98.2%) 114(2%) 19(95%) 17(100%)
Yes 555(1.3%) 3(1.8%) 2(1.7%) 1(5%) 0(0%)
Multiple pregnancy 1.000 0.674 0.380 1.000
No 43,066(99.2%) 165(99.4%) 116(100%) 19(95%) 17(100%)
Yes 336(0.8%) 1(0.6%) 0(0%) 1(5%) 0(0%)
Season of conception 0.412 0.281 0.555 0.877
Spring 11,324(26.1%) 54(32.5%) 38(32.8%) 3(15%) 4(23.5%)
Summer 10,419(24.0%) 37(22.3%) 29(25.0%) 7(35%) 3(17.6%)
Autumn 9,928(22.9%) 33(19.9%) 25(21.6%) 4(20%) 5(29.4%)
Winter 11,731(27.0%) 42(25.3%) 24(20.7%) 6(30%) 5(29.4%)

The p-values were calculated using Two-sample t-test, Chi-square test, Fisher’s exact test or Mann–Whitney U test according to the type of variables. Variables with statistical significance were shown in boldface. Spring included March, April, and May. Summer included June, July, and August. Autumn included September, October, and November. Winter included December, January, and February. Q10–Q18: congenital malformations of eye, ear, face and neck; Q35–Q37: cleft lip and cleft palate; Q65–Q79: congenital malformations and deformations of the musculoskeletal system. C, contingency coefficient. *The value of C was shown when the Chi-square test showed that the difference in constituent ratio between the two groups was statistically significant and the correlation between the two variables exists.

3.2.2. Characteristics of parents of livebirths with birth defects

As shown in Table 3, paternal ages of livebirths in overall birth defects, Q65–Q79 and Q35–Q37 subgroups were older than those in the healthy group, and the proportion of fathers older than 40 years was higher in the overall birth defects and Q65–Q79 subgroup than that in the health group (closeness degree: 1.7 and 1.6%, respectively), whereas there was no relationship between birth defects and paternal age in the Q10–Q18 subgroup. There was no significant difference in the composition ratio of race, occupation, education level, household registration address and nature between the health group and birth defect groups.

Table 3.

Characteristics of fathers of newborns with birth defects.

Variables Health group
(n = 43,402)
Birth defect group p/C*
Overall (n = 166) Q65–Q79
(n = 116)
Q35–Q37
(n = 20)
Q10–Q18
(n = 17)
Overall Q65–Q79 Q35–Q37 Q10–Q18
Age (year) 31.01 ± 4.92 32.56 ± 5.16 32.61 ± 5.06 33.72 ± 5.60 31.47 ± 3.94 <0.001 0.001 0.019 0.718
<40 37,832(87.2%) 139(83.7%) 98(84.5%) 16(80%) 14(82.4%) <0.001/0.017 0.002/0.016 0.616 0.580
≥40 2,250(5.2%) 19(11.4%) 14(12.1%) 2(10%) 1(5.9%)
Not stated 3,320(7.6%) 8(4.8%) 4(3.4%) 2(10%) 2(11.8%)
Race
Han 43,271(99.7%) 164(98.8%) 114(98.3%) 20(100%) 17(100%) 0.092 0.054 0.941 0.950
Minority 131(0.3%) 2(1.2%) 2(1.7%) 0(0%) 0(0%)
Local inhabitant
Yes 43,005(99.1%) 165(99.4%) 115(99.1%) 20(100%) 17(100%) 0.551 1.000 0.832 1.000
No 397(0.9%) 1(0.6%) 1(0.9%) 0(0%) 0(0%)
The nature of household registration 0.280 0.488 0.490 1.000
Agriculture 41,966(96.7%) 163(98.2%) 114(98.3%) 19(95%) 17(100%)
Non-agricultural 1,436(3.3%) 3(1.8%) 2(1.7%) 1(5%) 0(0%)
Occupation 0.906 0.828 0.309 0.871
Staff of administrative, enterprise or institution 29,328(67.6%) 113(68.1%) 82(70.7%) 12(60%) 13(76.5%)
Freelancer 5,727(13.2%) 23(13.9%) 14(12.1%) 5(25%) 2(11.8%)
Other practitioners 8,347(19.2%) 30(18.1%) 17(14.7%) 3(15%) 2(11.8%)
Education 0.873 0.863 0.735 1.000
Junior middle school or below 1,875(4.3%) 6(3.6%) 4(3.4%) 1(5%) 0(0%)
High school or technical school 36,232(83.5%) 139(83.7%) 97(83.6%) 17(85%) 16(94.1%)
College or above 895(2.1%) 2(1.2%) 1(0.9%) 0(0%) 0(0%)
Not stated 4,400(10.1%) 19(11.4%) 14(12.1%) 2(10%) 1(5.9%)

The p-values were calculated using Two-sample t test, Chi-square test, Fisher’s exact test or Mann–Whitney U test according to the type of variables. Variables with statistical significance were shown in boldface. Q10–Q18: congenital malformations of eye, ear, face and neck; Q35–Q37: cleft lip and cleft palate; Q65–Q79: congenital malformations and deformations of the musculoskeletal system. C, contingency coefficient. *The value of C was shown when the Chi-square test showed that the difference in constituent ratio between the two groups was statistically significant and the correlation between the two variables exists.

As shown in Table 4, mothers of livebirths with birth defect were significantly older than those of healthy newborns, and the proportion of the mothers aged 35 years or older was higher. However, the associations between maternal age and birth defect were observed only in the overall birth defect and Q65–Q79 subgroup with a small magnitude of 0.013 and 0.014. No significant difference in the composition ratio of race, occupation, education level, household registration address and nature between the two groups, as well as in the mean of height, were observed.

Table 4.

Basic characteristics of mothers of newborns with birth defects.

Variables Health group
(n = 43,402)
Birth defect group p/C*
Overall (n = 166) Q65–Q79
(n = 116)
Q35–Q37
(n = 20)
Q10–Q18
(n = 17)
Overall Q65–Q79 Q35–Q37 Q10–Q18
Age (year) 28.11 ± 4.48 29.32 ± 4.66 29.46 ± 4.73 28.95 ± 4.67 28.88 ± 4.63 0.001 0.001 0.401 0.476
<35 years old 39,543(91.1%) 141(84.9%) 97(83.6%) 17(85%) 16(94.1%) 0.005/0.013 0.005/0.014 0.416 1.000
≥35 years old 3,859(8.9%) 25(15.1%) 19(16.4%) 3(15%) 1(5.9%)
Height (cm) 159.09 ± 5.94 160.05 ± 4.99 159.87 ± 5.22 158.80 ± 6.74 160.11 ± 5.69 0.084 0.240 0.851 0.605
Race 0.624 0.139 1.000 1.000
Han 42,922(98.9%) 163(98.2%) 113(97.4%) 20(100%) 17(100%)
Minority 480(1.1%) 3(1.8%) 3(2.6%) 0(0%) 0(0%)
Local inhabitant 0.388 0.910 0.064 0.052
Yes 36,123(83.2%) 134(80.7%) 97(83.6%) 13(65%) 11(64.7%)
No 7,279(16.8%) 32(19.3%) 19(16.4%) 7(35%) 6(35.3%)
The nature of household registration 0.974 0.621 1.000 0.626
Agriculture 38,990(89.8%) 148(89.2%) 103(88.8%) 18(90%) 17(100%)
Non-agricultural 2,869(6.6%) 11(6.6%) 9(7.8%) 1(5%) 0(0%)
Not stated 1,543(3.6%) 7(4.2%) 4(3.4%) 1(5%) 0(0%)
Occupation 0.569 0.746 0.566 0.135
Staff of administrative, enterprise or institution 28,408(65.5%) 106(3.9%) 78(67.2%) 12(60%) 9(52.9%)
Freelancer 7,079(16.3%) 32(19.3%) 20(17.2%) 5(25%) 6(35.3%)
Other practitioners 7,915(18.2%) 28(16.9%) 18(15.5%) 3(15%) 2(11.8%)
Education 0.652 0.487 0.598 0.886
Junior middle school or below 4,298(9.9%) 16(9.6%) 9(7.8%) 3(15%) 2(11.8%)
High school or technical school 34,261(78.9%) 129(77.7%) 90(77.6%) 15(75%) 15(88.2%)
College or above 2,150(5.0%) 9(5.4%) 8(6.9%) 1(5%) 0(0%)
Not stated 2,693(6.2%) 12(7.2%) 9(7.8%) 1(5%) 0(0%)

The p-values were calculated using Two-sample t-test, Chi-square test, Fisher’s exact test or Mann–Whitney U test according to the type of variables. Variables with statistical significance were shown in boldface. Q10–Q18: congenital malformations of eye, ear, face and neck; Q35–Q37: cleft lip and cleft palate; Q65–Q79: congenital malformations and deformations of the musculoskeletal system. C: contingency coefficient. *The value of C was shown when the Chi-square test showed that the difference in constituent ratio between the two groups was statistically significant and the correlation between the two variables exists.

As shown in Table 5, compared with mothers of healthy newborns, mothers of livebirths with birth defects gained weight more quickly during pregnancy based on a higher basal weight before pregnancy although no significant difference, so that they had a higher weight at delivery. Subgroup analysis showed that this phenomenon was mainly evident in the Q65–Q79 subgroup, while no statistical differences were observed in the other subgroups. The 95% CI of weight at delivery of mothers in the health group ranged from 58.19 kg to 76.55 kg, while it ranged from 60.27 kg to 82.73 kg in the Q65–Q79 subgroup’ mothers, indicating that some mothers in the Q65–Q79 subgroup reached a weight at delivery of more than 80 kg. As we mentioned above (2.3 Definition), a maternal weight of more than 80 kg is a clinically meaningful risk weight. Therefore, the association between maternal weight at delivery and birth defects of Q65–Q79 May be meaningful, but further studies with larger sample sizes are needed to verify it. In addition, mothers in overall birth defects group and Q65–Q79 subgroup had higher first-trimester fasting blood glucose. However, this minor difference May not be clinically significant, which did not result in fasting blood glucose values outside the normal reference range (3.9–6.1 mmol/L) in both the health group and the overall birth defects, as well as the subgroups. Moreover, mothers of birth defect group had higher gravidity and parity, and a higher proportion of exposure to suspected teratogens, high-risk pregnancies, and history of abnormal pregnancy-labor. However, Contingency coefficient showed that the associations of these variables with birth defects were not strong. There was no significant difference in blood pressure and menstruation. Among the mothers, 13.4% were underweight (BMI: <18.5 kg/m2), 66.2% were normal weight (BMI: 18.5–23.9 kg/m2), 18.5% were overweight (BMI: 24.0–29.9 kg/m2), and 1.9% were obese (BMI: ≥30 kg/m2) (not shown).

Table 5.

Clinical characteristics of mothers of newborns with birth defects.

Variables Health group
(n = 43,402)
Birth defect group p/C*
Overall
(n = 166)
Q65–Q79
(n = 116)
Q35–Q37
(n = 20)
Q10–Q18
(n = 17)
Overall Q65–Q79 Q35–Q37 Q10–Q18
Basal weight (kg) 55.31 ± 8.84 56.57 ± 10.78 57.12 ± 11.49 55.39 ± 10.88 57.26 ± 7.08 0.185 0.135 0.973 0.464
Weight at 24–28 weeks of gestation (kg) 61.74 ± 8.70 63.79 ± 10.42 64.68 ± 10.99 61.66 ± 8.57 61.74 ± 8.30 0.062 0.032 0.978 0.999
Weight at delivery (kg) 67.37 ± 9.18 70.70 ± 10.65 71.50 ± 11.23 69.87 ± 11.06 67.94 ± 7.60 <0.001 0.001 0.291 0.816
Weight gained (kg) 12.38 ± 5.24 13.53 ± 5.23 13.33 ± 5.10 15.33 ± 4.75 10.88 ± 5.99 0.017 0.098 0.042 0.343
Basal systolic blood pressure (mmHg) 108.26 ± 10.59 109.37 ± 10.16 109.7 ± 10.05 107.8 ± 10.76 113.1 ± 8.91 0.251 0.207 0.868 0.148
Basal Diastolic blood pressure (mmHg) 68.14 ± 8.23 68.86 ± 8.68 69.20 ± 8.67 67.27 ± 7.35 70.30 ± 7.50 0.343 0.239 0.680 0.408
Number of prenatal visits (time) 5.53 ± 2.83 5.83 ± 2.69 5.88 ± 2.65 5.93 ± 2.31 5.07 ± 3.05 0.220 0.235 0.584 0.543
First-trimester fasting blood glucose 4.68 ± 0.59 4.85 ± 0.58 4.94 ± 0.62 4.67 ± 0.40 4.60 ± 0.24 0.012 0.001 0.901 0.744
Gravidity (time) <0.001/0.019 <0.001/0.019 0.127 0.049/0.010
1–2 27,696(63.8%) 86(51.8%) 81(69.8%) 14(70%) 11(64.7%)
≥3 15,706(36.2%) 80(48.2%) 35(30.2%) 6(30%) 6(35.3%)
Parity (time) 0.025/0.012 0.138 0.291 0.003/0.024
1–2 42,663(98.3%) 159(95.8%) 112(96.6%) 19(95%) 14(82.4%)
≥3 739(1.7%) 7(4.2%) 4(3.4%) 1(5%) 3(17.6%)
Age of menarche (year) 13.04 ± 0.65 12.95 ± 0.74 12.88 ± 0.71 13.20 ± 1.09 13.40 ± 0.55 0.373 0.219 0.585 0.217
Menstrual period (day) 5.31 ± 0.90 5.30 ± 0.79 5.40 ± 0.82 4.75 ± 0.50 6.00 ± 1.16 0.958 0.650 0.214 0.140
Menstrual cycle (day) 29.41 ± 2.27 29.23 ± 1.10 29.25 ± 1.16 28.50 ± 1.00 29.00 ± 1.16 0.675 0.757 0.424 0.720
Abnormal pregnancy-labor history 0.041/0.010 0.228 0.357 0.125
No 28,140(64.8%) 95(57.2%) 69(59.5%) 11(55%) 8(47.1%)
Yes 15,262(35.2%) 71(42.8%) 47(40.5) 9(45%) 9(52.9%)
History of miscarriage or induced labor 0.004/0.014 0.042/0.010 0.412 0.054
No 34,049(78.5%) 115(69.3%) 82(70.7%) 14(70%) 10(58.8%)
Yes 9,353(21.5%) 51(30.7%) 34(29.3%) 6(30%) 7(41.2%)
High-risk pregnancy 0.001/0.016 <0.001/0.017 0.432 0.691
No 27,546(63.5%) 84(50.6%) 55(47.4%) 11(55%) 10(58.8%)
Yes 15,856(36.5%) 82(49.4%) 61(52.6%) 9(45%) 7(41.2%)
Exposure to suspected teratogens in the first trimester of pregnancy 0.032/0.011 0.086 0.446 1.000
No 42,141(97.1%) 156(94.0) 109(94%) 19(95%) 17(100%)
Yes 1,261(2.9%) 10(6.0%) 7(6%) 1(5%) 0(0%)

The p-values were calculated using Two-sample t-test, Chi-square test or Fisher’s exact test. Variables with statistical significance were shown in boldface. Q10–Q18: congenital malformations of eye, ear, face and neck; Q35–Q37: cleft lip and cleft palate; Q65–Q79: congenital malformations and deformations of the musculoskeletal system. C, contingency coefficient. *The value of C was shown when the Chi-square test showed that the difference in constituent ratio between the two groups was statistically significant and the correlation between the two variables exists.

3.3. Risk factors for birth defects

The results of Poisson regression are shown in Tables 69. Overall, several risk factors are associated with birth defects, and the risk factors vary dramatically across specific defects. One risk factor May be associated with several defects, and one defect May be associated with several risk factors. Regression analysis showed that advanced paternal age (≥40 years) and excessive maternal weight at delivery (≥80 kg) were independent risk factors for overall birth defects. Gender of livebirths and excessive maternal weight at delivery (≥80 kg) and Gravidity ≥3times were independent risk factor for Q65–Q79. Among all the factors analyzed, Q35–Q37 was only affected by father’s age, and Q10–Q18 was only affected by parity ≥3 times. Moreover, as the calendar year increases, the risk of birth defects increases. Given that paternal age and maternal weight were independent risk factors for overall birth defects, we further analyzed trends of these two factors from 2015 to 2022, the results were shown in Figures 4, 5. The results showed that both the age of parents and maternal weight at delivery showed an upward trend.

Table 6.

Risk factor for overall birth defects.

Variables Univariate analysis Multivariate analysis
Crude PRR (95%CI) p Adjusted PRR (95%CI) p
Fetus
Gender
Female 1.00 1.00
Male 1.669(1.216, 2.291) 0.002 1.400(0.882,2.223) 0.154
Father
Age (year)
<40 1.00 1.00
≥40 2.287(1.416, 3.694) 0.001 2.532(1.201,5.336) 0.015
Mother
Age (year)
<35 1.00 1.00
≥35 1.812(1.184, 2.772) 0.006 0.661(0.298,1.466) 0.308
Weight at delivery (kg)
<80 1.00 1.00
≥80 2.170(1.404, 3.352) <0.001 1.785(1.006,3.166) 0.048
First-trimester fasting blood glucose 1.418(1.098, 1.832) 0.008 1.203(0.860,1.683) 0.281
Gravidity (time)
1–2 times 1.00 1.00
≥3times 1.980(1.412, 2.775) <0.001 1.623(0.907,2.904) 0.103
Parity (time)
1–2 times 1.00 1.00
≥3 times 2.527(1.185, 5.387) 0.016 0.749(0.177,3.167) 0.694
History of abnormal pregnancy-labor
No 1.00 1.00
Yes 1.376(1.012, 1.872) 0.042 0.757(0.371,1.545) 0.444
History of miscarriage or induced labor
No 1.00 1.00
Yes 1.611(1.159, 2.240) 0.005 1.182(0.606,2.307) 0.623
High-risk pregnancy
No 1.00 1.00
Yes 1.692(1.248, 2.294) 0.001 1.604(0.854,3.013) 0.142
Exposure to suspected teratogens in the first trimester of pregnancy
No 1.00 1.00
Yes 2.133(1.126, 4.043) 0.020 1.670(0.745,3.741) 0.213
Calendar year 1.406(1.298, 1.523) <0.001 1.399(1.215, 1.610) <0.001

Variables with statistical significance were shown in boldface. CI, confidence intervals; PRR, prevalence rate ratio.

Table 9.

Risk factor for Q10–Q18.

Variables Univariate analysis Multivariate analysis
Crude PRR (95%CI) p Adjusted PRR (95%CI) p
Mother
Gravidity (time)
1–2 times 1.00 1.00
≥3 times 2.742(1.014, 7.413) 0.047 1.822(0.597,5.565) 0.292
Parity (time)
1–2 times 1.00 1.00
≥3 times 12.325(3.542, 42.887) <0.001 8.751(2.159, 35.478) 0.002

Variables with statistical significance were shown in boldface. Q10–Q18: congenital malformations of eye, ear, face and neck. CI, confidence intervals; PRR, prevalence rate ratio.

Figure 4.

Figure 4

The trends of childbearing age of parents.

Figure 5.

Figure 5

The trends of maternal weight.

Table 7.

Risk factor for Q65–Q79.

Variables Univariate analysis Multivariate analysis
Crude PRR (95%CI) p Adjusted PRR (95%CI) p
Fetus
Gender
Female 1.00 1.00
Male 1.605(1.101, 2.340) 0.014 1.624(1.059, 2.490) 0.026
Father
Age (year)
<40 1.00 1.00
≥40 2.393(1.367, 4.190) 0.002 1.774(0.856, 3.679) 0.123
Mother
Age (year)
<35 1.00 1.00
≥35 2.002(1.224, 3.274) 0.006 1.049(0.521,2.109) 0.894
Weight at delivery (kg)
<80 1.00 1.00
≥80 2.408(1.455, 3.987) 0.001 2.153(1.282, 3.614) 0.004
Gravidity (time)
1–2 times 1.00 1.00
≥3times 2.167(1.458, 3.222) <0.001 2.062(1.238, 3.433) 0.005
History of miscarriage or induced labor
No 1.00 1.00
Yes 1.508(1.011, 2.249) 0.044 1.013(0.616,1.667) 0.959
High-risk pregnancy
No 1.00 1.00
Yes 1.923(1.336, 2.769) 0.001 1.239(0.765,2.006) 0.385

Variables with statistical significance were shown in boldface. Q65–Q79: congenital malformations and deformations of the musculoskeletal system. CI, confidence intervals; PRR, prevalence rate ratio.

Table 8.

Risk factor for Q35–Q37.

Variables Univariate analysis Multivariate analysis
Crude PRR (95%CI) p Adjusted PRR (95%CI) p
Father
Age (year) 1.100(1.016,1.191) 0.019 1.141(1.045,1.258) 0.004
Mother
Weight gained (kg) 1.104(1.004,1.214) 0.040 1.090(0.987,1.204) 0.088

Variables with statistical significance were shown in boldface. Q35–Q37: cleft lip and cleft palate. CI, confidence intervals; PRR, prevalence rate ratio.

4. Discussion

Hubei Province is located in the central region of China, with well-developed transportation and relatively well medical condition in China. Our study showed that the overall livebirths prevalence of birth defects from 2015 to 2022 in Jingzhou city, Hubei Province, China, is 3.81per 1,000 livebirths, which is lower than the prevalence of other areas of China. The prevalence of birth defects in Hunan Province, which borders Hubei Province, was 19.18 per 1,000 perinatal infants from 2005 to 2014 (4) and 22.05 per 1,000 perinatal infants from 2014 to 2018 (8). The prevalence of birth defects in Zhejiang Provinces located in eastern China was 18.32 per 1,000 births (9). The prevalence of birth defects in Guangxi Province located in southwest China was 12.17 per 1,000 perinatal infants (15). In addition, the prevalence rate in Hubei Province was obviously lower than those of other ethnic populations in other countries, such as Korean (28.69 per 1,000 livebirths, 2005–2006) (5), Europe (23.9 per 1,000 births, 2003–2007) (16) and Africa (23.5 per 1,000 newborns, 2023) (17). However, the prevalence in Hubei Province was similar to that in Jiangsu Province which was 7.15 per 1,000 perinatal infants (3). Similarly, the prevalence in our study population was lower than that of newborns born to Taiwan native-born mothers (28.6 per 1,000 newborns), but similar to newborns born to immigrants from mainland China (9.8 per 1,000 newborns) (14). Another study from Hubei Province also showed that the prevalence of birth defects which was 8 per 1,000 livebirths in this region was significantly lower than that in other regions, ranking in the moderate to lower level of China (18). In this study, the reasons for the low prevalence of birth defects in Hubei Province are mainly considered as follows: (1) the birth defects in our study were all diagnosed within 28 weeks of gestation to 7 days after birth, excluding fetuses aborted, induced and stillborn due to birth defects and newborns with birth defects diagnosed after 7 days after birth; (2) China implemented a universal two-child policy in 2016. The prevalence of birth defects was relatively low due to the relatively younger age of mothers and fewer gravidity and parity before the two-child policy, and, after the two-child policy implementation, the prevalence of birth defects increased significantly (9). Our study included data of newborns born in 2015 and 2016, which contributed to the overall low prevalence in our study; (3) Most of our subjects were from rural areas, where the prevalence of birth defects is lower than that in urban areas (14).

However, it is worth noting that the prevalence of our study in 2022 also reached 9.23 per 1,000 livebirths, showing a drastically uptrend. Moreover, consistent with the results of Lin et al. (14), the main type of birth defect in Hubei Province is congenital malformations and deformations of the musculoskeletal system (Q65–Q79) accounted for 68.4% and cleft lip and cleft palate (Q35–Q37) accounted for 11.7%, which were not fatal defects. In contrast, congenital heart disease, neural tube defects and Down syndrome, which were more common before (9, 15), showed small proportions in our study population. This May be attributed to the relatively advanced prenatal screening and diagnostic technology and policy supports in Hubei Province. This May be also one of the reasons why the livebirths prevalence of birth defects in Hubei Province is lower than those in other regions, because most fetuses with those serious birth defects were induced after prenatal diagnosis, which were excluded from the statistical analysis of this study. Moreover, this study included only livebirths birth defects detected within the first 7 days of life, which May contribute to the low prevalence of congenital heart disease showed in this study.

Moreover, our findings showed that January and February were the peak months for livebirths birth defects, although we did not identify significant difference in the prevalence rates of birth defects in different seasons of conception. Zhou et al. (3) reported the consistent results as ours in Jiangsu, China, while studies in other countries and regions have shown seasonal variations in birth defects (19–22). Benavides et al. (22) suggested that season of conception was associated with 5% of birth defects in Texas and summer conception was associated with any monitored birth defect and five specific phenotypes, most notably Hirschsprung disease. de la Vega and López-Cepero (19) detected a statistically significant increase in the incidence and relative risk during the summer months (using winter as a reference) of conceiving a child with open neural tube defects, cardiac anomalies, or cleft lip and palate in Puerto Rico. Possible reasons for this lack of consistency in findings include differences in populations, underlying factors, seasons or climates, diet and lifestyle, and methods of analysis between the studies. In our study, the majority of newborns delivered in January and February were conceived in April and May in spring. The highest rate of birth defects in our study was 32.5% in spring conception and the lowest was 19.9% in autumn conception. Women who were pregnant in spring were immediately subjected to summer and autumn when watermelon, lychee, durian and other high-sugar melons and fruits were ripe after the early pregnancy reaction, while women who were pregnant in autumn were followed by winter and spring when there were fewer high-sugar melons and fruits after the early pregnancy reaction. As a result, women who conceive in the spring were more likely to develop gestational diabetes mellitus and rapid weight gain, as well as other pregnancy complications that came with them. Diabetes and excess weight have both been reported to increase the risk of birth defects (11, 14, 23–26).

Our study showed that livebirths with specific birth defects had poorer health, earlier delivery gestational age, and were more likely to suffer from low body weight, which might carry medical, surgical, cosmetic, or lifestyle consequences (27). Moreover, perinatal infants with Q65–Q79 birth defects were predominantly male (62.9% vs. 37.1%, p = 0.001) and male newborns had a 1.624 times risk of birth defects than female newborns. This phenomenon has been verified in many studies (3, 4, 8). This might be due to several reasons. (1) Recessive defects on the father’s X chromosome are more likely to show up in boys. (2) Y chromosome has a higher susceptibility than X chromosome (28). (3) Female fetuses with birth defects are easier to be induced, while male fetuses with minor birth defects are more likely to be retained due to China’s traditional preference for sons. (4) The external genital deformities in males are more detectable than in females (4).

Previous studies have commonly studied the relationship between maternal factors and birth defects, while few studies on paternal factors. In this study, we also collected data on fathers of perinatal infants to analyze the influence of paternal factors on birth defects. Our study showed that the paternal ages of livebirths in overall birth defects, Q65–Q79 and Q35–Q37 subgroup were significantly higher than that in healthy group, and advanced paternal age (≥40 years) was an independent risk factor for overall birth defects and Q35–Q37. The association could be caused by mutations of the gametes in men induced by biological or environmental factors, because spontaneous mutations in germ cells increase with male age (29). Bu et al. (30) suggested that advanced paternal age > 44 years was associated with increased risk of congenital anomalies after adjusting confounding factors in the USA, mainly for the chromosomal anomalies, but not the structure anomalies. Gili et al. (31) believed that advanced paternal age was a risk factor for preaxial polydactyly in South American. A meta-analysis of Fang et al. (32) indicated that paternal age is associated with a moderate increase in the incidence of urogenital and cardiovascular abnormalities, facial deformities, and chromosome disorders. However, study of Hurley and DeFranco (33) did not find a correlation between paternal age and birth defects in Ohio of American. Similar, no differences in paternal age were observed between cases and controls in study of Nazer et al. (34). Thus, the influence of advanced paternal age on birth defects is related to race and region. Men in Hubei Province, China, should be advised to have children at the appropriate age, and expectant fathers with advanced age should pay more attention to prenatal screening and diagnosis. As a risk-based recommendation, Friedman (35) suggests that men should complete their families before age 40.

For mother’s factors, advanced age, rapid weight gain, excess weight at delivery, high first-trimester fasting blood glucose, more than 2 times of gravidity, more than 2 times of parity, abnormal pregnancy-labor history, history of miscarriage or induced labor, high-risk pregnancy and exposure to suspected teratogens in the first trimester of pregnancy all increased the risk of overall birth defects, while only excess weight at delivery (≥80 kg) was independent risk factors for birth defects (especially for Q65–Q79). Previous studies focused on mother’s pre-pregnancy weight (36–48), and few studies have paid attention to weight gain and weight at delivery. Obviously, in our study population, excess weight at delivery was the stronger factor than mother’s pre-pregnancy weight and weight gain during pregnancy. Previous studies have shown that pre-pregnancy overweight or obesity was associated with the increased risk of birth defects in population of Texas (39), Florida (40) and so on. However, this association was not significant in our study population. We considered that the limited sample size, low proportion of overweight (18.5%) and obese (1.9%) pregnant woman, and low prevalence of birth defects might lead to the insufficient sensitivity to this association in our study. It was reported that the percentage of overweight and obese pregnant woman was 67% in Texas (39) and 42.5% in Florida (40). Therefore, a larger sample size study is more suited to verify the relationship between pre-pregnancy weight and birth defects in Hubei Province of China in the future. In our study, the weight of mothers in the birth defect group was similar to that in the healthy group at pre-pregnancy (56.57 kg vs. Fifty five 0.31 kg, p = 0.185), showed borderline significance at 24–28 weeks of gestation (63.79 kg vs. Sixty one 0.74 kg, p = 0.062), and reached statistical significance at delivery (70.70 kg vs. Sixty seven 0.37 kg, p < 0.001), indicating that mothers in the birth defect group gained more weight during pregnancy than those in the healthy group. The difference of weight gained also showed statistical significance between the two groups in our study. However, variable of weight gained did not remain significant in multivariate regression, suggesting that weight gained was not as strongly associated with birth defects as weight at delivery. However, to our knowledge, this was the first study to analyze the relationship between weight at delivery and birth defects, so the mechanisms behind this association were unclear. The possible reason May be due to the fact that the weight at delivery was a result of continuous accumulation of pregnancy weight gained on the basis of pre-pregnancy weight, which reflected status of both pre-pregnancy weight and pregnancy weight gained. Pre-pregnancy overweight or obesity has been shown to increase the risk of birth defects, while rapid weight gain during pregnancy led to an increased risk of gestational diabetes mellitus (GDM) (41) which has been reported to increase the risk of birth defects (26). Of course, since GDM was typically diagnosed in the second trimester (24–28 gestational weeks), GDM should not be considered as a direct risk factor for birth defects but rather as a signal of a longer-term metabolic dysfunction of the mother, which affects at the time of meiosis and early pregnancy (26). Moreover, it was reported that obese pregnant women have increased inflammation and oxidative stress, and lower levels of nutritional antioxidant defenses compared with lean pregnant women, which may contribute to the adverse outcomes (42, 43). It was also reported that obese pregnant women transferred less 25(OH)D (44, 45) and iron (46) to their fetuses. In addition, pregnant women with exceeding weight at delivery tended to complicate pre-pregnancy diabetes or GDM, as well as many other pregnancy complications, which could increase the risk of birth defects (24, 47). Women with risk weight at delivery (80 kg) had either pre-pregnancy overweight or obesity, excessive gestational weight gain, or both. Women who had a higher pre-pregnancy weight and gained weight faster during pregnancy were more likely to subject to risk weight at delivery. The significance of pre-pregnancy overweight or obesity for pregnancy care May be limited, while simultaneously controlling pre-pregnancy weight and gestational weight gain to reduce weight at delivery May be more meaningful for the prevention of birth defects in Hubei Province where has a low proportion of obese pregnant women. In conclusion, weight control before pregnancy and physical exercise during pregnancy are crucial for obese pregnant women to control their weight at delivery and reduce the prevalence of birth defects (48).

Moreover, more than 2 times of gravidity was associated with an increased risk for Q65–Q79. The reasons are mainly considered as follows: (1) parents with more than 2 times of gravidity had an older age than those with gravidity≤2 times (34.61 years vs. Thirty 0.29 years for fathers and 31.60 years vs. Twenty seven 0.42 years for mothers in our study, all p < 0.001, not shown), and advanced age, especially advanced paternal age, was a risk factor for birth defects as we discussed above; (2) mothers with more than 2 times of gravidity managed their weight relatively poorly as the increase of their age (56.61 kg vs. Fifty five 0.05 kg for basal weight and 68.23 kg vs. Sixty seven 0.20 kg for weight at delivery in our study, all p < 0.001, not shown), which was a high-risk factor as we discussed above; (3) although China implemented a universal two-child policy in 2016 and three-child policy in 2021, the rate of newborn with more than 2 times of parity was only 1.7% (746/42822) in our study population. In other words, more mothers with more than 2 times of gravidity (16.6%, 7246/36322) in our study population usually had a history of miscarriage, induced labor or stillbirth, which were risk factors for birth defects (49). History of miscarriage or induced labor was not an independent risk factor for birth defects in our study because the data of birth defects on miscarriage, induced labor, and stillbirth was not included in our study. In addition, birth defects data from population-based birth defects surveillance system in China’s Jiangsu of Zhou et al. (50) also showed that gravidity ≥3 (PRR = 1.38) was risk factor for birth defects. Li et al. (51) reported that gravidity was associated with occurrence of congenital heart defects. Study of Zhang et al. (52) showed that the birth defect group had significantly higher gravidity than the control group. In addition, more than 2 times of parity was associated with an increased risk for Q10–Q79. The reason May be similar to excess gravidity. Therefore, mothers with more than 2 times of gravidity or parity should strengthen prenatal screening. However, pregnant women with risk factors mentioned above should all pay more attention to prenatal screening and diagnosis.

The reason that paternal age was an independent risk factor for birth defects while maternal age had a relatively small effect on birth defects May be partly attribute to the older mean childbearing age of fathers than that of mothers (31.02 ± 4.91 vs. 28.11 ± 4.48). As early as 1955, Penrose (53) demonstrated that the statistical association between parental ages and birth defects caused by fresh dominant mutations was largely attributable to the age of the father, not to mother’s age. Study of Lian and Zack (54) similarly indicated that older fathers had a higher risk for birth defects, while an equivalent association for older mothers was not found. These results indicated that results were flawed to some extent when risk factors were analyzed considering only the age of the mother.

It is worth noting that the livebirths prevalence of birth defects in our study showed a remarkable uptrend. Moreover, as the calendar year increased, the risk of birth defects for livebirths increased by 41.5% for each additional year. Study of Zhao et al. (2) based on the GBD2019 dataset showed that the variation trend of incidence for birth defects between 1990 and 2019 globally was not statistically significant, but showed an increasing trend in China (p < 0.001), with an annually percentage changes of 0.26%, and the upward trend was projected to continue between 2020 and 2030. The similar dramatic upward trend was also observed in China’s Jiangsu province (3), Guangxi province (7, 15), Hunan province (4) and Zhejiang province (9). Regarding etiology, although in many cases the intrinsic cause is still unexplicit, it has been hypothesized that birth defects May be caused by complex interactions between genes and environment, which modify the normal embryo-fetal development, especially during the organogenesis phase (55). The increasing risk and prevalence of birth defects May, to a large extent, attribute to deteriorating living and working environment, changes in lifestyle and habits, and changed conception on family planning. The air and drinking water quality deteriorated because of the rapid development of industry and the popularization of cars. It was reported that nitrate, agrichemicals and chlorination in drinking water during pregnancy increased the risk of birth defects (56–58). Several studies suggested that exposure to common air pollutants (SO2, PM2.5, PM10, NO2, O3, and CO) increased the risk of birth defects (59), with the maximum effect in the 7th or 8th week for PM2.5, the 7th week for SO2, the 8th week for PM10, the 7th week for NO2, and the 31st or 32nd week for O3 (60). Moreover, the fast pace of work and life, the increasing pressure from study and work, the convenient transportation and the online shopping, work and communication all contributed to fewer opportunities to exercise and weight gained (61, 62). With the enrichment of material life, a variety of sugar-sweetened beverages and foods and meat diet also led to obesity (63, 64). Obviously, obesity increases the risk of birth defects as shown in our study, and the weight at delivery of the mothers in our study increased from 66.04 kg in 2015 to 69.88 kg in 2022. In addition, the average childbearing age for mothers in our study increased from 26.69 years in 2015 to 29.52 years in 2022, and for fathers from 29.46 years in 2015 to 32.69 years in 2022. The childbearing age of the parents, especially the age of fathers, was a crucial factor affecting birth defects as shown in our study. On the other hand, the continuous advancement of medical level led to the induction of serious birth defects, the Decreased rate of stillbirth and the increased prevalence of birth defects in live births (2). Since birth defect represents a significant public health issue, an effective primary prevention strategy should be a priority for public policies and healthcare system.

Although we collected the detailed data for analysis, our study also had some shortcomings. First, our sample size was not very large, which limited the explore for risk factors, trend, seasonality of specific birth defect. Second, our study did not include data on miscarriage, induced labor and birth defects diagnosed after 7 days of birth, while most of the fetuses aborted or induced were due to birth defects, and many birth defects were not detected during 7 days after delivery. Third, although we collected fasting blood glucose values at the first trimester, information on pregestational diabetes and gestational diabetes was not collected due to the data incompleteness, though both of which have been reported to be associated with birth defects. Fourth, we did not analyze the relationship between maternal and paternal smoking and alcohol consumption and birth defects, because we found that many subjects hid these histories when we collect and collate the relevant data. Fifth, the study sample was from only one county which was not a representative sample, and the results cannot be generalized. Sixth, exposure to certain heavy metals like lead and arsenic, as well as the socio-economic status of the participant which might be risk factors for birth defects were not included into our study because they were not recorded in the database.

5. Conclusion

The livebirths prevalence and risk of birth defects in a county of Hubei Province of China showed a remarkable uptrend and elevated paternal age, excess maternal weight, gravidity or parity might be added to the array of factors that prospective parents consider when planning their families which warrants further investigations.

Funding Statement

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by ethics committees of Jingzhou Hospital Affiliated to Yangtze University (number: 2022–049-01) and Gongan County Maternal and Child Health Care Hospital (number: 2022-02-01). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements.

Author contributions

PL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. QL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Writing – original draft. BY: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft. YX: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing – original draft. TL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft. XD: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft. BM: Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry. (1994) 31:188–205. PMID: [PubMed] [Google Scholar]
  • 2.Zhao Y, Zhang H, Peng M, Zhou Y, Cheng X, Yang S, et al. The burden of congenital birth defects between 1990 and 2019 in China: an observational study. Front Pediatr. (2023) 11:1170755. doi: 10.3389/fped.2023.1170755, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhou Y, Mao X, Zhou H, Qin Z, Wang L, Cai Z, et al. Epidemiology of birth defects based on a birth defect surveillance system in southern Jiangsu, China, 2014-2018. J Matern Fetal Neonatal Med. (2022) 35:745–51. doi: 10.1080/14767058.2020.1731459, PMID: [DOI] [PubMed] [Google Scholar]
  • 4.Xie D, Yang T, Liu Z, Wang H. Epidemiology of birth defects based on a birth defect surveillance system from 2005 to 2014 in Hunan Province, China. PLoS One. (2016) 11:e0147280. doi: 10.1371/journal.pone.0147280, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kim MA, Yee NH, Choi JS, Choi JY, Seo K. Prevalence of birth defects in Korean livebirths, 2005-2006. J Korean Med Sci. (2012) 27:1233–40. doi: 10.3346/jkms.2012.27.10.1233, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Feldkamp ML, Carey JC, Byrne JLB, Krikov S, Botto LD. Etiology and clinical presentation of birth defects: population based study. BMJ. (2017) 357:j2249. doi: 10.1136/bmj.j2249, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yang X, Zeng J, Gu Y, Fang Y, Wei C, Tan S, et al. Birth defects data from hospital-based birth defect surveillance in Guilin, China, 2018-2020. Front Public Health. (2022) 10:961613. doi: 10.3389/fpubh.2022.961613, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xiong L, Chen Q, Wang A, Kong F, Xie D, Xie Z. The differences of population birth defects in epidemiology analysis between the rural and urban areas of Hunan Province in China, 2014-2018. Biomed Res Int. (2021) 2021:2732983. doi: 10.1155/2021/2732983, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhang X, Chen L, Wang X, Wang X, Jia M, Ni S, et al. Changes in maternal age and prevalence of congenital anomalies during the enactment of China's universal two-child policy (2013-2017) in Zhejiang Province, China: an observational study. PLoS Med. (2020) 17:e1003047. doi: 10.1371/journal.pmed.1003047, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dolan SM, Gross SJ, Merkatz IR, Faber V, Sullivan LM, Malone FD, et al. The contribution of birth defects to preterm birth and low birth weight. Obstet Gynecol. (2007) 110:318–24. doi: 10.1097/01.AOG.0000275264.78506.63 [DOI] [PubMed] [Google Scholar]
  • 11.Luo P, Fan Y, Xiong Y, Zhang C, Yang Z, Sun F, et al. Metabolic characteristics of gestational diabetes mellitus and the effects on pregnancy outcomes. Diabetes Metab Syndr Obes. (2023) 16:15–29. doi: 10.2147/DMSO.S390999, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cheng YW, Chung JH, Kurbisch-Block I, Inturrisi M, Shafer S, Caughey AB. Gestational weight gain and gestational diabetes mellitus: perinatal outcomes. Obstet Gynecol. (2008) 112:1015–22. doi: 10.1097/AOG.0b013e31818b5dd9 [DOI] [PubMed] [Google Scholar]
  • 13.Obstetrics Subgroup . Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guideline of preconception and prenatal care. Chin J Perinat Med. (2018) 21:145–52. doi: 10.3760/cma.j.issn.1007-9408.2018.03.001 [DOI] [Google Scholar]
  • 14.Lin YJ, Chiou JY, Huang JY, Su PH, Chen JY, Yang HJ. A comparative prevalence of birth defects between newborns of immigrant and native-born mothers in Taiwan: ten years of population-based data. Int J Environ Res Public Health. (2021) 18:12530. doi: 10.3390/ijerph182312530, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Peng Z, Wei J, Chen B, Huang X, Song P, Liang L, et al. Epidemiology of birth defects based on a birth defects surveillance system in southwestern China and the associated risk factors. Front Pediatr. (2023) 11:1165477. doi: 10.3389/fped.2023.1165477, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. (2010) 686:349–64. doi: 10.1007/978-90-481-9485-8_20 [DOI] [PubMed] [Google Scholar]
  • 17.Moges N, Anley DT, Zemene MA, Adella GA, Solomon Y, Bantie B, et al. Congenital anomalies and risk factors in Africa: a systematic review and meta-analysis. BMJ Paediatr Open. (2023) 7:e002022. doi: 10.1136/bmjpo-2023-002022, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gong LY, Mao ZF, Li XD. Analysis of birth defects in 1997-2002 in Hubei Province. Zhonghua Liu Xing Bing Xue Za Zhi. (2004) 25:881. PMID: [PubMed] [Google Scholar]
  • 19.de la Vega A, López-Cepero R. Seasonal variations in the incidence of some congenital anomalies in Puerto Rico based on the timing of conception. P R Health Sci J. (2009) 28:121–5. PMID: [PubMed] [Google Scholar]
  • 20.Siffel C, Alverson CJ, Correa A. Analysis of seasonal variation of birth defects in Atlanta. Birth Defects Res A Clin Mol Teratol. (2005) 73:655–62. doi: 10.1002/bdra.20207, PMID: [DOI] [PubMed] [Google Scholar]
  • 21.Caton AR. Exploring the seasonality of birth defects in the New York state congenital malformations registry. Birth Defects Res A Clin Mol Teratol. (2012) 94:424–37. doi: 10.1002/bdra.23006, PMID: [DOI] [PubMed] [Google Scholar]
  • 22.Benavides E, Lupo PJ, Langlois PH, Schraw JM. A comprehensive assessment of the associations between season of conception and birth defects, Texas, 1999-2015. Int J Environ Res Public Health. (2020) 17:7120. doi: 10.3390/ijerph17197120, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. (2008) 199:237.e1–9. doi: 10.1016/j.ajog.2008.06.028, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wu Y, Liu B, Sun Y, Du Y, Santillan MK, Santillan DA, et al. Association of maternal prepregnancy diabetes and gestational diabetes mellitus with congenital anomalies of the newborn. Diabetes Care. (2020) 43:2983–90. doi: 10.2337/dc20-0261, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Parnell AS, Correa A, Reece EA. Pre-pregnancy obesity as a modifier of gestational diabetes and birth defects associations: a systematic review. Matern Child Health J. (2017) 21:1105–20. doi: 10.1007/s10995-016-2209-4, PMID: [DOI] [PubMed] [Google Scholar]
  • 26.Kinnunen J, Nikkinen H, Keikkala E, Mustaniemi S, Gissler M, Laivuori H, et al. Gestational diabetes is associated with the risk of offspring's congenital anomalies: a register-based cohort study. BMC Pregnancy Childbirth. (2023) 23:708. doi: 10.1186/s12884-023-05996-6, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Harris BS, Bishop KC, Kemeny HR, Walker JS, Rhee E, Kuller JA. Risk factors for birth defects. Obstet Gynecol Surv. (2017) 72:123–35. doi: 10.1097/OGX.0000000000000405 [DOI] [PubMed] [Google Scholar]
  • 28.Sokal R, Tata LJ, Fleming KM. Sex prevalence of major congenital anomalies in the United Kingdom: a national population-based study and international comparison meta-analysis. Birth Defects Res A Clin Mol Teratol. (2014) 100:79–91. doi: 10.1002/bdra.23218, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhu JL, Madsen KM, Vestergaard M, Olesen AV, Basso O, Olsen J. Paternal age and congenital malformations. Hum Reprod. (2005) 20:3173–7. doi: 10.1093/humrep/dei186 [DOI] [PubMed] [Google Scholar]
  • 30.Bu X, Ye W, Zhou J. Paternal age, risk of congenital anomalies, and birth outcomes: a population-based cohort study. Eur J Pediatr. (2023) 182:3519–26. doi: 10.1007/s00431-023-05025-w, PMID: [DOI] [PubMed] [Google Scholar]
  • 31.Gili JA, Rittler M, Heisecke S, Campaña H, Giménez L, Santos MR, et al. Paternal age and risk for selected birth defects in a large south American sample. Birth Defects Res. (2023) 115:1866–75. doi: 10.1002/bdr2.2252 [DOI] [PubMed] [Google Scholar]
  • 32.Fang Y, Wang Y, Peng M, Xu J, Fan Z, Liu C, et al. Effect of paternal age on offspring birth defects: a systematic review and meta-analysis. Aging. (2020) 12:25373–94. doi: 10.18632/aging.104141, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hurley EG, DeFranco EA. Influence of paternal age on perinatal outcomes. Am J Obstet Gynecol. (2017) 217:566.e1–6. doi: 10.1016/j.ajog.2017.07.034, PMID: [DOI] [PubMed] [Google Scholar]
  • 34.Nazer HJ, Cifuentes OL, Millán ZF, Vacarisas AP, Köbrich Sch S, Aguila RA. Paternal age as a risk factor for congenital malformations. Rev Med Chile. (2008) 136:201–8. doi: 10.4067/S0034-98872008000200009 [DOI] [PubMed] [Google Scholar]
  • 35.Friedman JM. Genetic disease in the offspring of older fathers. Obstet Gynecol. (1981) 57:745–9. PMID: [PubMed] [Google Scholar]
  • 36.Oddy WH, De Klerk NH, Miller M, Payne J, Bower C. Association of maternal pre-pregnancy weight with birth defects: evidence from a case-control study in Western Australia. Aust N Z J Obstet Gynaecol. (2009) 49:11–5. doi: 10.1111/j.1479-828X.2008.00934.x, PMID: [DOI] [PubMed] [Google Scholar]
  • 37.Jadresić L, Au H, Woodhouse C, Nitsch D. Pre-pregnancy obesity and risk of congenital abnormalities of the kidney and urinary tract (CAKUT)-systematic review, meta-analysis and ecological study. Pediatr Nephrol. (2021) 36:119–32. doi: 10.1007/s00467-020-04679-0, PMID: [DOI] [PubMed] [Google Scholar]
  • 38.Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. (2007) 161:745–50. doi: 10.1001/archpedi.161.8.745, PMID: [DOI] [PubMed] [Google Scholar]
  • 39.Marengo L, Farag NH, Canfield M. Body mass index and birth defects: Texas, 2005-2008. Matern Child Health J. (2013) 17:1898–907. doi: 10.1007/s10995-012-1214-5, PMID: [DOI] [PubMed] [Google Scholar]
  • 40.Block SR, Watkins SM, Salemi JL, Rutkowski R, Tanner JP, Correia JA, et al. Maternal pre-pregnancy body mass index and risk of selected birth defects: evidence of a dose-response relationship. Paediatr Perinat Epidemiol. (2013) 27:521–31. doi: 10.1111/ppe.12084, PMID: [DOI] [PubMed] [Google Scholar]
  • 41.Peng Y, Han N, Su T, Zhou S, Bao H, Ji Y, et al. Gestational weight gain and the risk of gestational diabetes mellitus: a latent class trajectory analysis using birth cohort data. Diabetes Res Clin Pract. (2021) 182:109130. doi: 10.1016/j.diabres.2021.109130, PMID: [DOI] [PubMed] [Google Scholar]
  • 42.Sen S, Iyer C, Meydani SN. Obesity during pregnancy alters maternal oxidant balance and micronutrient status. J Perinatol. (2014) 34:105–11. doi: 10.1038/jp.2013.153, PMID: [DOI] [PubMed] [Google Scholar]
  • 43.Jiménez-Osorio AS, Carreón-Torres E, Correa-Solís E, Ángel-García J, Arias-Rico J, Jiménez-Garza O, et al. Inflammation and oxidative stress induced by obesity, gestational diabetes, and preeclampsia in pregnancy: role of high-density lipoproteins as vectors for bioactive compounds. Antioxidants. (2023) 12:1894. doi: 10.3390/antiox12101894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pena HR, de Lima MC, Brandt KG, de Antunes MM, da Silva GA. Influence of preeclampsia and gestational obesity in maternal and newborn levels of vitamin D. BMC Pregnancy Childbirth. (2015) 15:112. doi: 10.1186/s12884-015-0547-7, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Josefson JL, Feinglass J, Rademaker AW, Metzger BE, Zeiss DM, Price HE, et al. Maternal obesity and vitamin D sufficiency are associated with cord blood vitamin D insufficiency. J Clin Endocrinol Metab. (2013) 98:114–9. doi: 10.1210/jc.2012-2882, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dao MC, Sen S, Iyer C, Klebenov D, Meydani SN. Obesity during pregnancy and fetal iron status: is Hepcidin the link? J Perinatol. (2013) 33:177–81. doi: 10.1038/jp.2012.81, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Loeken MR. Mechanisms of congenital malformations in pregnancies with pre-existing diabetes. Curr Diab Rep. (2020) 20:54. doi: 10.1007/s11892-020-01338-4, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Barakat R, Refoyo I, Coteron J, Franco E. Exercise during pregnancy has a preventative effect on excessive maternal weight gain and gestational diabetes. A randomized controlled trial. Braz J Phys Ther. (2019) 23:148–55. doi: 10.1016/j.bjpt.2018.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Campaña H, Rittler M, Gili JA, Poletta FA, Pawluk MS, Gimenez LG, et al. Association between a maternal history of miscarriages and birth defects. Birth Defects Res. (2017) 109:254–61. doi: 10.1002/bdra.23563 [DOI] [PubMed] [Google Scholar]
  • 50.Zhou Y, Mao X, Zhou H, Wang L, Qin Z, Cai Z, et al. Birth defects data from population-based birth defects surveillance system in a district of southern Jiangsu, China, 2014-2018. Front Public Health. (2020) 8:378. doi: 10.3389/fpubh.2020.00378, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Li H, Luo M, Zheng J, Luo J, Zeng R, Feng N, et al. An artificial neural network prediction model of congenital heart disease based on risk factors: a hospital-based case-control study. Medicine. (2017) 96:e6090. doi: 10.1097/MD.0000000000006090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Zhang Y, Jia W, Zeng F, Sun J. Independent factors associated with birth defects during the whole of pregnancy in Shenyang City, China: a case-control study. Transl Pediatr. (2023) 12:719–30. doi: 10.21037/tp-23-197, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Penrose LS. Parental age and mutation. Lancet. (1955) 266:312–3. doi: 10.1016/s0140-6736(55)92305-9 [DOI] [PubMed] [Google Scholar]
  • 54.Lian ZH, Zack MM, Erickson JD. Paternal age and the occurrence of birth defects. Am J Hum Genet. (1986) 39:648–60. PMID: [PMC free article] [PubMed] [Google Scholar]
  • 55.Baldacci S, Gorini F, Santoro M, Pierini A, Minichilli F, Bianchi F. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence. Epidemiol Prev. (2018) 42:1–34. doi: 10.19191/EP18.3-4.S1.P001.057, PMID: [DOI] [PubMed] [Google Scholar]
  • 56.Stayner LT, Jensen AS, Schullehner J, Coffman VR, Trabjerg BB, Olsen J, et al. Nitrate in drinking water and risk of birth defects: findings from a cohort study of over one million births in Denmark. Lancet Reg Health Eur. (2022) 14:100286. doi: 10.1016/j.lanepe.2021.100286, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Winston JJ, Emch M, Meyer RE, Langlois P, Weyer P, Mosley B, et al. Hypospadias and maternal exposure to atrazine via drinking water in the National Birth Defects Prevention study. Environ Health. (2016) 15:76. doi: 10.1186/s12940-016-0161-9, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Hwang BF, Magnus P, Jaakkola JJ. Risk of specific birth defects in relation to chlorination and the amount of natural organic matter in the water supply. Am J Epidemiol. (2002) 156:374–82. doi: 10.1093/aje/kwf038, PMID: [DOI] [PubMed] [Google Scholar]
  • 59.Huang Z, Qiu Y, Qi J, Ma X, Cheng Q, Wu J. Association between air pollutants and birth defects in Xiamen, China. Front Pediatr. (2023) 11:1132885. doi: 10.3389/fped.2023.1132885, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sun S, Zhang Q, Sui X, Ding L, Liu J, Yang M, et al. Associations between air pollution exposure and birth defects: a time series analysis. Environ Geochem Health. (2021) 43:4379–94. doi: 10.1007/s10653-021-00886-2, PMID: [DOI] [PubMed] [Google Scholar]
  • 61.Celik O, Yildiz BO. Obesity and physical exercise. Minerva Endocrinol. (2021) 46:131–44. doi: 10.23736/S2724-6507.20.03361-1 [DOI] [PubMed] [Google Scholar]
  • 62.Ferrari G, Drenowatz C, Kovalskys I, Gómez G, Rigotti A, Cortés LY, et al. Walking and cycling, as active transportation, and obesity factors in adolescents from eight countries. BMC Pediatr. (2022) 22:510. doi: 10.1186/s12887-022-03577-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Malik VS, Hu FB. The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nat Rev Endocrinol. (2022) 18:205–18. doi: 10.1038/s41574-021-00627-6, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Dabbagh-Moghadam A, Mozaffari-Khosravi H, Nasiri M, Miri A, Rahdar M, Sadeghi O. Association of white and red meat consumption with general and abdominal obesity: a cross-sectional study among a population of Iranian military families in 2016. Eat Weight Disord. (2017) 22:717–24. doi: 10.1007/s40519-017-0385-x, PMID: [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Public Health are provided here courtesy of Frontiers Media SA

RESOURCES